Table 3.

Time-dependent FLR change by baseline characteristics.

	Baseline		1 mo		1–3 mo		3–6 mo		6–9 mo		>9 mo
	n	FLR	n	FLR	n	FLR	n	FLR	n	FLR	n	FLR
PVT
No	46	24 (9–45)	45	26 (9–45)	15	26 (11–40)	25	30 (14–44)	20	32 (15–45)	22	37 (15–55)
Yes	37	29 (15–57)	35	30 (17–58)	19	35 (19–57)	17	41 (22–64)	8	41 (36–59)	3	37 (37–55)
p value	<0.001		0.002		0.03		0.02		0.01		0.40
CP score
<7	49	24 (9–47)	47	26 (9–58)	21	26 (11–56)	27	37 (14–64)	21	37 (15–54)	20	38 (15–55)
≥7	34	29 (10–57)	33	29 (13–58)	13	35 (24–57)	15	34 (14–57)	7	32 (30–59)	5	37 (31–45)
p value	0.01		0.05		0.06		0.89		0.94		0.95
Tumor type
HCC	67	27 (12–47)	65	29 (9–58)	29	33 (13–57)	33	37 (14–64)	23	36 (15–59)	18	37 (15–55)
CC	8	25 (17–57)	8	26 (20–58)	3	26 (23–52)	3	42 (30–57)	1	38	2	37 (33–41)
CRC	8	16 (9–24)	7	18 (12–35)	2	16 (11–22)	6	24 (14–39)	4	33 (23–42)	5	39 (23–43)
HCC vs. CRC p value	<0.001		0.01		0.04		0.03		0.68		0.77
HCC vs. CC p value	0.99		0.86		0.72		0.26		n.a.		1.00
CRC vs. CC p value	0.01		0.02		0.08		0.07		n.a.		0.70
Cirrhosis (imaging or biopsy)
No	36	24 (9–57)	33	27 (9–58)	14	30 (11–56)	19	36 (14–64)	15	36 (15–57)	14	36 (15–55)
Yes	47	27 (14–45)	45	28 (13–58)	20	31 (22–57)	23	37 (14–45)	13	36 (19–48)	11	39 (23–55)
p value	0.24		0.85		0.65		0.89		0.98		0.30

n.a., not available.